Cargando…
Efficacy evaluation of chimeric antigen receptor-modified human peritoneal macrophages in the treatment of gastric cancer
BACKGROUND: Gastric cancer is one of the most common cancers. Peritoneal carcinomatosis (PC) appears to be the most common pattern of recurrence, and more than half of the GC patients eventually die from PC. Novel strategies for the management of patients with PC are urgently needed. Recently, rapid...
Autores principales: | Dong, Xuhui, Fan, Jiqiang, Xie, Wangxu, Wu, Xiang, Wei, Jia, He, Zhonglei, Wang, Wenxin, Wang, Xueting, Shen, Pingping, Bei, Yuncheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403530/ https://www.ncbi.nlm.nih.gov/pubmed/37386139 http://dx.doi.org/10.1038/s41416-023-02319-6 |
Ejemplares similares
-
Chimeric antigen receptor macrophage therapy for breast tumours mediated by targeting the tumour extracellular matrix
por: Zhang, Wenlong, et al.
Publicado: (2019) -
Chimeric antigen receptor modified T-cells for cancer treatment
por: Han, Xiao, et al.
Publicado: (2018) -
Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
por: Dai, Hanren, et al.
Publicado: (2016) -
Galunisertib enhances chimeric antigen receptor-modified T cell function
por: Wang, Zhixiong, et al.
Publicado: (2020) -
Crosstalk between IL‐15Rα(+) tumor‐associated macrophages and breast cancer cells reduces CD8(+) T cell recruitment
por: Zhang, Wenlong, et al.
Publicado: (2022)